Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

Source: Article title. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vdr knockout (Vdr−/−, n = 9), wild-type (WT or Vdr+/+, n = 8), and heterozygous (Vdr−/+, n = 4) male mice were obtained by crossing Vdr−/+ mice.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

Study design awaiting verification · International Journal of Molecular Sciences · 2023

Original publication title

Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

Miguel A. Olivencia; Marta Villegas-Esguevillas; Maria Sancho; Bianca Barreira; Elena Paternoster; Rui Adão; María Jesús Larriba; Angel Cogolludo; Francisco Perez-Vizcaino

© 2023 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Recent evidence suggests that vitamin D is involved in the development of pulmonary arterial hypertension (PAH). The aim of this study was to analyze the electrophysiological and contractile properties of pulmonary arteries (PAs) in vitamin D receptor knockout mice (Vdr−/−). PAs were dissected and mounted in a wire myograph. Potassium membrane currents were recorded in freshly isolated PA smooth muscle cells (PASMCs) using the conventional whole-cell configuration of the patch-clamp technique. Potential vitamin D response elements (VDREs) in Kv7 channels coding genes were studied, and their protein expression was analyzed. Vdr−/− mice did not show a pulmonary hypertensive phenotype, as neither right ventricular hypertrophy nor endothelial dysfunction was apparent.

However, resistance PA from these mice exhibited increased response to retigabine, a Kv7 activator, compared to controls and heterozygous mice. Furthermore, the current sensitive to XE991, a Kv7 inhibitor, was also higher in PASMCs from knockout mice. A possible VDRE was found in the gene coding for KCNE4, the regulatory subunit of Kv7.4. Accordingly, Vdr−/− mice showed an increased expression of KCNE4 in the lungs, with no changes in Kv7.1 and Kv7.4. These results indicate that the absence of Vdr in mice, as occurred with vitamin D deficient rats, is not sufficient to induce PAH.

However, the contribution of Kv7 channel currents to the regulation of PA tone is increased in Vdr−/− mice, resembling animals and humans suffering from PAH.

Authors’ abstract

Recent evidence suggests that vitamin D is involved in the development of pulmonary arterial hypertension (PAH). The aim of this study was to analyze the electrophysiological and contractile properties of pulmonary arteries (PAs) in vitamin D receptor knockout mice (Vdr−/−). PAs were dissected and mounted in a wire myograph. Potassium membrane currents were recorded in freshly isolated PA smooth muscle cells (PASMCs) using the conventional whole-cell configuration of the patch-clamp technique. Potential vitamin D response elements (VDREs) in Kv7 channels coding genes were studied, and their protein expression was analyzed. Vdr−/− mice did not show a pulmonary hypertensive phenotype, as neither right ventricular hypertrophy nor endothelial dysfunction was apparent.

However, resistance PA from these mice exhibited increased response to retigabine, a Kv7 activator, compared to controls and heterozygous mice. Furthermore, the current sensitive to XE991, a Kv7 inhibitor, was also higher in PASMCs from knockout mice. A possible VDRE was found in the gene coding for KCNE4, the regulatory subunit of Kv7.4. Accordingly, Vdr−/− mice showed an increased expression of KCNE4 in the lungs, with no changes in Kv7.1 and Kv7.4. These results indicate that the absence of Vdr in mice, as occurred with vitamin D deficient rats, is not sufficient to induce PAH.

However, the contribution of Kv7 channel currents to the regulation of PA tone is increased in Vdr−/− mice, resembling animals and humans suffering from PAH.

Publication and source details

Original title: Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

Miguel A. Olivencia; Marta Villegas-Esguevillas; Maria Sancho; Bianca Barreira; Elena Paternoster; Rui Adão; María Jesús Larriba; Angel Cogolludo; Francisco Perez-Vizcaino

International Journal of Molecular Sciences · 2023

* Correspondence: fperez@med.ucm.es
†

These authors contributed equally to this work.

© 2023 by the authors.2023https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Agencia Estatal de InvestigaciónPID2019-104867RB-I00PID2020-117939RB-I00PID/AEI/10.13039/501100011033Instituto de Salud Carlos III: Fondo Europeo de Desarrollo RegionalCIBERES/CB06/06/1084CIBERONC/CB16/12/00273Fundación contra la hipertensión pulmonarUniversidad Complutense/Banco SantanderCT63/19-CT64/19European Union’s Horizon 2020 research and innovation programme847635The work in the authors’ laboratories is funded by the Agencia Estatal de Investigación (PID2019-104867RB-I00 and PID2020-117939RB-I00, PID/AEI/10.13039/501100011033), the Instituto de Salud Carlos III: Fondo Europeo de Desarrollo Regional (CIBERES/CB06/06/1084 and CIBERONC/CB16/12/00273), and the Fundación contra la hipertensión pulmonar (FCHP). M.J.L. belongs to the Spanish National Research Council (CSIC)’s Cancer Hub. M.A.O. is funded by Universidad Complutense/Banco Santander CT63/19-CT64/19. R.A. has received funding from the European Union’s Horizon 2020 research and innovation programme under Marie-Curie grant agreement Nº 847635.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:23:43.882749+00:00

DOI: 10.3390/ijms241512350 · PMC10418734